Target intelligence / Profile preview

Antigen presentation (by the host immune system)

Molecular classification
Other (Biological process)
01

Overview

Antigen presentation is a central immunological process where antigen-presenting cells (such as dendritic cells, macrophages, and B cells) capture, process, and display peptide fragments of proteins (antigens) on their cell surface bound to major histocompatibility complex (MHC) molecules. This display enables recognition of "self" and "non-self" antigens by T cells, leading to activation of adaptive immune responses. Class I MHC presents intracellular antigens to CD8+ cytotoxic T cells, while class II MHC presents extracellular antigens to CD4+ helper T cells. Efficient antigen presentation is crucial for immunity against infections and cancer, but dysregulation contributes to autoimmunity or immune evasion by tumors

Other names
Antigen processing and presentationAntigen presentation pathwayMHC-mediated antigen presentation
02

Mechanism of action

Enhancement of MHC expression to increase immune detection of disease (e.g., in cancer) Inhibition or modulation of antigen presentation to reduce autoimmune or inflammatory responses (experimental)

03

Biological functions

Immune responseAdaptive immunityT cell activationSurveillance for infection and cancer
04

Disease associations

CancerInfectionInflammationAutoimmune disease
05

Safety considerations

Immune-related adverse events, such as autoimmunity (when antigen presentation is enhanced or dysregulated)Loss of antigen presentation (as a resistance mechanism in cancer)
06

Interacting drugs

Immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab; these do not directly target antigen presentation but augment T cell responses that rely on effective antigen presentation)

1 more in the full profile.

07

Biomarkers

MHC class I and II expression levels (on tumor or immune cells)Tumor mutational burden (for cancer immunotherapies)Peptide-MHC complexes (imaging and research biomarkers)

Beyond the preview

Go deeper on Antigen presentation (by the host immune system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen presentation (by the host immune system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call